Anifrolumab for the treatment of refractory chilblain lupus erythematosus - Michael J. Woodbury, BS; Katherine Nabel Smith, PhD; Jeffrey S. Smith, MD, PhD; Joseph F. Merola, MD, MMSc (Elsevier, 2024)